Showing results (421-430 of 884) with videos related to

Sort By:
Pageof 89
Therapeutic Advances in Gastroenterology|November 11, 2024
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trialsCharlie W Lees, Joana Torres, Yvette Leung, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2013
The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based studyNicole M Gentile, Sahil Khanna, Edward V Loftus, et al.
The American Journal of Gastroenterology|September 13, 2008
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's diseaseKelvin T Thia, William J Sandborn, James D Lewis, et al.
Gastroenterology|June 18, 2021
Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)Laurent Peyrin-Biroulet, Edward V Loftus, Jean-Frédéric Colombel, et al.
Inflammatory Bowel Diseases|November 23, 2006
A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitisJeanne Tung, Edward V Loftus, Deborah K Freese, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trialsLaurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.
Inflammatory Bowel Diseases|December 24, 2005
Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practiceAshish Chopra, Darrell S Pardi, Edward V Loftus, et al.
Health and Quality of Life Outcomes|March 10, 2012
Experiences of patients with chronic gastrointestinal conditions: in their own wordsJennifer B McCormick, Rachel R Hammer, Ruth M Farrell, et al.
Inflammatory Bowel Diseases|July 6, 2022
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis ProgramEdward V Loftus, Daniel C Baumgart, Krisztina Gecse, et al.
Mayo Clinic Proceedings|September 18, 2012
Asthma and proinflammatory conditions: a population-based retrospective matched cohort studyHyun D Yun, Erin Knoebel, Yilma Fenta, et al.
Pageof 89